Počet záznamov: 1
levodopa
SYS d007980 LBL 00000nx--j22000003--45-- 005 20240119201041.3 100 $a 19990101csloy0103----ba0 152 $b mesh 250 $a levodopa $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 75; was see DOPA 1972-74 $8 eng 300 1-
$a Dopa (1966-1974) $8 eng 330 1-
$a The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. $8 eng 450 $a L-Dopa $5 e $8 eng 450 $a L-DOPA $5 e $8 slo 550 $3 sllk_un_auth*d004298 $Y Dopamine $5 B $a dopamín 550 $3 sllk_un_auth*d000978 $Y Antiparkinson Agents $5 P $a antiparkinsoniká 550 $3 sllk_un_auth*d015259 $Y Dopamine Agents $5 P $a látky dopamínové 550 $3 sllk_un_auth*d004298 $Y Dopamine $5 F $a dopamín 686 $a D02.092.311.200.480 686 $a D02.455.426.559.389.657.166.175.200.480 686 $a D12.125.072.050.685.400.500 686 $a D12.125.072.050.875.130.500 750 $a Levodopa $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 20070706 980 $x M
Počet záznamov: 1